MedTrace Logo

Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance

NCT00796874 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-07-25

No results posted yet for this study

Summary

RATIONALE: Sometimes prostate cancer may not need treatment until it progresses. In this case, active surveillance may be sufficient. Diagnostic procedures, such as magnetic resonance imaging, may be a less invasive method of finding prostate cancer that has progressed.

PURPOSE: This clinical trial is studying how well magnetic resonance imaging works in detecting cancer progression in patients with early-stage prostate cancer who are undergoing active surveillance.

Conditions

Interventions

OTHER

active surveillance

Correlative Study

OTHER

imaging biomarker analysis

Correlative Study

PROCEDURE

biopsy

Tissue Removal

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

Radiolical Medical Imaging

PROCEDURE

magnetic resonance imaging

Radiolical Medical Imaging

PROCEDURE

magnetic resonance spectroscopic imaging

Radiolical Medical Imaging

Sponsors & Collaborators

  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Anurag K. Singh, MD · Roswell Park Cancer Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-07-31
Completion
2013-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00796874 on ClinicalTrials.gov